Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kimberly E Rousseau"'
Autor:
Laura K. Aisenberg, Kimberly E. Rousseau, Katherine Cascino, Guido Massaccesi, William H. Aisenberg, Wensheng Luo, Kar Muthumani, David B. Weiner, Stephen S. Whitehead, Michael A. Chattergoon, Anna P. Durbin, Andrea L. Cox
Publikováno v:
JCI Insight, Vol 7, Iss 12 (2022)
The Aedes aegypti mosquito transmits both dengue virus (DENV) and Zika virus (ZIKV) . Individuals in endemic areas are at risk for infection with both viruses, as well as for repeated DENV infection. In the presence of anti-DENV antibodies, outcomes
Externí odkaz:
https://doaj.org/article/b518d8789686457aafe5b023c2ac3a9d
Autor:
Han-Sol Park, Janna R. Shapiro, Ioannis Sitaras, Bezawit A. Woldemeskel, Caroline C. Garliss, Amanda Dziedzic, Jaiprasath Sachithanandham, Anne E. Jedlicka, Christopher A. Caputo, Kimberly E. Rousseau, Manjusha Thakar, San Suwanmanee, Pricila Hauk, Lateef Aliyu, Natalia I. Majewska, Sushmita Koley, Bela Patel, Patrick Broderick, Giselle Mosnaim, Sonya L. Heath, Emily S. Spivak, Aarthi Shenoy, Evan M. Bloch, Thomas J. Gniadek, Shmuel Shoham, Arturo Casadevall, Daniel Hanley, Andrea L. Cox, Oliver Laeyendecker, Michael J. Betenbaugh, Steven M. Cramer, Heba H. Mostafa, Andrew Pekosz, Joel N. Blankson, Sabra L. Klein, Aaron A.R. Tobian, David Sullivan, Kelly A. Gebo
Publikováno v:
JCI Insight, Vol 7, Iss 5 (2022)
Benchmarks for protective immunity from infection or severe disease after SARS-CoV-2 vaccination are still being defined. Here, we characterized virus neutralizing and ELISA antibody levels, cellular immune responses, and viral variants in 4 separate
Externí odkaz:
https://doaj.org/article/1448fb71cc4d4418b5b5b5d6f96c013c
Publikováno v:
Nucleic Acids Research
Cyclic-G/AMP (cGAMP) synthase (cGAS) triggers host innate immune responses against cytosolic double-stranded (ds)DNA arising from genotoxic stress and pathogen invasion. The canonical activation mechanism of cGAS entails dsDNA-binding and dimerizatio
Autor:
Han-Sol Park, Janna R. Shapiro, Ioannis Sitaras, Bezawit A. Woldemeskel, Caroline C. Garliss, Amanda Dziedzic, Jaiprasath Sachithanandham, Anne E. Jedlicka, Christopher A. Caputo, Kimberly E. Rousseau, Manjusha Thakar, San Suwanmanee, Pricila Hauk, Lateef Aliyu, Natalia I. Majewska, Sushmita Koley, Bela Patel, Patrick Broderick, Giselle Mosnaim, Sonya L. Heath, Emily S. Spivak, Aarthi Shenoy, Evan M. Bloch, Thomas J. Gniadek, Shmuel Shoham, Arturo Casadevall, Daniel Hanley, Andrea L. Cox, Oliver Laeyendecker, Michael J. Betenbaugh, Steven M. Cramer, Heba H. Mostafa, Andrew Pekosz, Joel N. Blankson, Sabra L. Klein, Aaron A.R. Tobian, David Sullivan, Kelly A. Gebo
Publikováno v:
JCI insight. 7(5)
Benchmarks for protective immunity from infection or severe disease after SARS-CoV-2 vaccination are still being defined. Here, we characterized virus neutralizing and ELISA antibody levels, cellular immune responses, and viral variants in 4 separate
Autor:
Shruti H. Mehta, Andrea L. Cox, Sho K. Sugawara, Ramy El-Diwany, Joel N. Blankson, Rebecca T. Veenhuis, Laura K. Cohen, David L. Thomas, Christopher Y.K. Williams, Kimberly E Rousseau, Ashwin Balagopal
Publikováno v:
J Virol
HIV-1 infection persists in humans despite expression of antiviral type 1 interferons (IFN). Even exogenous administration of IFNα only marginally reduces HIV-1 abundance, raising the hypothesis that people living with HIV-1 (PLWH) are refractory to
Autor:
Kimberly E Rousseau, Elisa Scarselli, Matthew E. Winter, Kimberly Page, Karla Thornton, Ellen Stein, Andrea L. Cox, Michael R. Wierzbicki, Paula J. Lum, Soju Chang, Antonella Folgori, Alfredo Nicosia, Guido Massaccesi, Michael Forman, Katherine Wagner, Marc G. Ghany, Alice Asher, Linda C. Giudice, T. Jake Liang, Elaine Thomas, Stefania Capone, William O. Osburn, Rebecca T. Veenhuis, Lan Lin, Richard L. Gorman, Michael T. Melia, Ventzislav Vassilev
Publikováno v:
N Engl J Med
The New England journal of medicine, vol 384, iss 6
The New England journal of medicine, vol 384, iss 6
BACKGROUND: A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of efforts to eliminate the disease. METHODS: In this phase 1–2 randomized, double-blind, placebo-controlled trial, we evaluated a
Autor:
Wouter A. van der Linden, Jing-wen Lin, Shahid M. Khan, Kimberly E Rousseau, Kirsten K. Hanson, Christine S. Hopp, Photini Sinnis, Satish Mishra, Christine Lehmann, Brandy L. Bennett, Matthew Bogyo, Volker Heussler, Filomena A. Carvalho, Nuno C. Santos
Publikováno v:
PLoS Pathogens, Vol 13, Iss 9, p e1006586 (2017)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
PLoS Pathogens, 13(9)
Hopp, Christine S; Bennett, Brandy L; Mishra, Satish; Lehmann, Christine; Hanson, Kirsten K; Lin, Jing-Wen; Rousseau, Kimberly; Carvalho, Filomena A; van der Linden, Wouter A; Santos, Nuno C; Bogyo, Matthew; Khan, Shahid M; Heussler, Volker; Sinnis, Photini (2017). Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites. PLoS pathogens, 13(9), e1006586. Public Library of Science 10.1371/journal.ppat.1006586
PLoS Pathogens
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
PLoS Pathogens, 13(9)
Hopp, Christine S; Bennett, Brandy L; Mishra, Satish; Lehmann, Christine; Hanson, Kirsten K; Lin, Jing-Wen; Rousseau, Kimberly; Carvalho, Filomena A; van der Linden, Wouter A; Santos, Nuno C; Bogyo, Matthew; Khan, Shahid M; Heussler, Volker; Sinnis, Photini (2017). Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites. PLoS pathogens, 13(9), e1006586. Public Library of Science 10.1371/journal.ppat.1006586
PLoS Pathogens
© 2017 Hopp et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cred